Intrinsic Value of S&P & Nasdaq Contact Us

Biotricity, Inc. BTCY OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
46/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.00
+1381.9%

Biotricity, Inc. (BTCY) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 2 Buy, 2 Hold.

The consensus price target is $4.00, representing an upside of 1381.9% from the current price $0.27.

BTCY Stock — 12-Month Price Forecast

$4.00
▲ +1,381.92% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Biotricity, Inc., the price target is $4.00.
The average price target represents a +1,381.92% change from the last price of $0.27.

BTCY Analyst Ratings

Buy
4
Ratings
2 Buy
2 Hold
Based on 4 analysts giving stock ratings to Biotricity, Inc. in the past 3 months
Rating breakdown
Buy
2 50%
Hold
2 50%
50%
Buy
2 analysts
50%
Hold
2 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message